The DOI matches its Crossref record; 58 of the 59 references it cites were found in a registry or an index.
Direct Binding of Smad1 and Smad4 to Two Distinct Motifs Mediates Bone Morphogenetic Protein-specific Transcriptional Activation ofId1 Gene
Open accessAbstract
Bone morphogenetic proteins (BMPs) are potent inhibitors of myoblast differentiation and inducers of bone formation both in vivo and in vitro. Expression of Id1, a negative regulator of basic helix-loop-helix transcription factors, is up-regulated by BMPs and contributes to the antimyogenic effects of this family of cytokines. In this report, we have identified a specific BMP-2 immediate early response enhancer in the human Id1 gene. Transcriptional activation of the enhancer was increased by overexpression of BMP-responsive Smads, and Smad4 and was completely abrogated in Smad4-deficient cells. Deletion analysis demonstrates that the responsive region is composed of two separate DNA binding elements, a set of overlapping GC boxes, which bind BMP-regulated Smads upon BMP stimulation, and three repeats of CAGAC boxes. Gel shift and oligonucleotide pull-down assays demonstrated that these two types of motifs were capable of binding their corresponding Smads. However, deletion or mutation of either DNA binding element was nonadditive, since disruption of either GC or CAGAC boxes resulted in complete or severe loss of BMP-2 responsiveness. These data suggest the simultaneous requirement of two independent DNA binding elements to allow functional cooperativity of BMP-regulated Smads and Smad4 in BMP-activated gene promoters.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“As a major receptor-activated SMADs (R-SMADs) downstream of BMP pathway, SMAD1 has been reported to repress Lgr5+ stem cell signature genes, thereby limiting stem cell expansion and maintaining intestinal homeostasis.50–52”
From Paneth-like transition drives resistance to dual targeting of KRAS and EGFR in colorectal cancer (2026) · cites this paper as [51]
Citations
Cites
TGFβ Signaling in Growth Control, Cancer, and Heritable Disorders
Massagué, J., Blain, S. W., & Lo, R. S. (2000) · Cell · doi:10.1016/s0092-8674(00)00121-5 · Cited by 2,391
Self-citationThe protein Id: A negative regulator of helix-loop-helix DNA binding proteins
Benezra, R., Davis, R. L., Lockshon, D., Turner, D. L., & Weintraub, H. M. (1990) · Cell · doi:10.1016/0092-8674(90)90214-y · Cited by 2,202
Transcriptional control by the TGF‐β/Smad signaling system
Massagué, J., & Wotton, D. (2000) · The EMBO Journal · doi:10.1093/emboj/19.8.1745 · Cited by 1,990
Self-citationDennler, S., Itoh, S., Vivien, D., ten Dijke, P., Huet, S., & Gauthier, J. (1998) · The EMBO Journal · doi:10.1093/emboj/17.11.3091 · Cited by 1,793
Katagiri, T. (1994) · The Journal of Cell Biology · doi:10.1083/jcb.127.6.1755 · Cited by 1,452
Adipogenesis and Obesity: Rounding Out the Big Picture
Spiegelman, B. M., & Flier, J. S. (1996) · Cell · doi:10.1016/s0092-8674(00)81359-8 · Cited by 1,262
Human Smad3 and Smad4 Are Sequence-Specific Transcription Activators
Zawel, L. S., Dai, J. L., Buckhaults, P., Zhou, S., Kinzler, K. W., Vogelstein, B., & Kern, S. E. (1998) · Molecular Cell · doi:10.1016/s1097-2765(00)80061-1 · Cited by 940
Id1 and Id3 are required for neurogenesis, angiogenesis and vascularization of tumour xenografts
Lyden, D. C., Young, A. Z., Zagzag, D., Yan, W. X., Gerald, W. L., O'Reilly, R., Bader, B., Hynes, R. O., Zhuang, Y., Manova, K., et al. (1999) · Nature · doi:10.1038/44334 · Cited by 912
Bone Cell Differentiation and Growth Factors
Urist, M. R., DeLange, R. J., & Finerman, G. A. M. (1983) · Science · doi:10.1126/science.6403986 · Cited by 875
Specificity, diversity, and regulation in TGF‐β superfamily signaling
Piek, E., Heldin, C., & ten Dijke, P. (1999) · The FASEB Journal · doi:10.1096/fasebj.13.15.2105 · Cited by 837
Research works printed but not linked: 1
- Norton, 1998, Trends Cell Biol., 8, 58
Cited by
Sorted by citations
Smad transcription factorsPreprint
Massagué, J., Seoane, J., & Wotton, D. (2005) · Genes & Development · doi:10.1101/gad.1350705 · Cited by 2,519
Self-citationYing, Q.-L., Nichols, J., Chambers, I., & Smith, A. G. (2003) · Cell · doi:10.1016/s0092-8674(03)00847-x · Cited by 2,114
Bi, Y., Ehirchiou, D., Kilts, T. M., Inkson, C. A., Embree, M. C., Sonoyama, W., Li, L., Leet, A. I., Seo, B., Zhang, L., et al. (2007) · Nature Medicine · doi:10.1038/nm1630 · Cited by 1,488
Basic FGF and suppression of BMP signaling sustain undifferentiated proliferation of human ES cells
Xu, R., Peck, R. M., Li, D. S., Feng, X., Ludwig, T. E., & Thomson, J. A. (2005) · Nature Methods · doi:10.1038/nmeth744 · Cited by 973
BMP receptor signaling: Transcriptional targets, regulation of signals, and signaling cross-talk
Miyazono, K., Maeda, S., & Imamura, T. (2005) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2005.01.009 · Cited by 910
Metadata
- Authors
- López-Rovira, T., Chalaux, E., Massagué, J., Rosa, J. L., & Ventura, F.
- Affiliations
- Universitat de Barcelona (ES)
- Memorial Sloan Kettering Cancer Center (US)
- Corresponding author
- Ventura, Francesc
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2002-02
- Volume
- 277
- Issue
- 5
- Pages
- 3176-3185
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W1994377715
- Cited by
- 285
- References
- 59
- Citations by year
- 2026: 3 · 2025: 5 · 2023: 5 · 2022: 4 · 2021: 4 · 2020: 10 · 2019: 12 · 2018: 6 · 2017: 8 · 2016: 8 · 2015: 11 · 2014: 15 · 2013: 16 · 2012: 15
- FWCI
- 7.86
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Dipòsit Digital de la Universitat de Barcelona (Universitat de Barcelona) (submittedVersion, public-domain)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › TGF-β signaling in diseases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Developmental Biology and Gene Regulation
- Keywords
- Smad1, SMAD4, bone morphogenetic proteins, BMP-2, transcriptional activation, enhancers, Sp1 binding site, DNA-binding motifs, myogenesis, bHLH transcription factors, gene expression regulation
- MeSH terms
- Animals, Binding Sites, Cell Line, Cloning, Molecular, DNA-Binding Proteins, Gene Expression Regulation, Kinetics, Luciferases, Promoter Regions, Genetic, Recombinant Proteins, Repressor Proteins, Transcription Factors, Transfection, Signal Transduction, Transcriptional Activation, Trans-Activators, Transforming Growth Factor beta, Genes, Reporter, Helix-Loop-Helix Motifs, Bone Morphogenetic Proteins, Smad Proteins, Inhibitor of Differentiation Protein 1, Bone Morphogenetic Protein 2
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
